Product release notes
Every shipped change to the platform — new features, performance improvements, integration updates. Honest about what changed and why.
Newsletters
Product, practice, and compliance — straight from the team
Product release notes, clinical practice notes, and compliance perspective. New posts every couple of weeks. Subscribe and we'll send each new post when it goes up — nothing else.
- Release notes
- Clinical practice
- Compliance + security
Latest posts
51 posts from the team
The newest at the top. Each post is a 4–7 minute read.
What 50 clinics across 6 countries told us about AI medical scribe ROI
We pulled anonymised time-study and billing data from 50 partner clinics across Australia, the US, UK, New Zealand, Canada, and Singapore. The patterns repeat — but the maths is different in every country.
ReadAnnual Wellness Visit (G0438/G0439): the $200 Medicare visit most US family physicians under-document
AWVs are the easiest billable Medicare visit on the schedule — yet 41% of eligible US Medicare patients never receive one. Here's what your scribe should be doing about it.
ReadQOF in 2026: the seven indicators most UK GP practices leave unclaimed every year
Every UK practice manager knows roughly where QOF points sit. Almost none can tell you which specific indicators their practice consistently underperforms — costing the average practice £18,400 in unclaimed funding per year.
ReadWhy your AI medical scribe needs a real dark mode — not a dim filter
Half of GP consult-room screens spend half their life past sunset. A clinical-grade dark theme is not a vanity feature — it changes accuracy, dictation focus, and end-of-day cognitive load.
ReadFive years of one care plan: what longitudinal GPMP / CCMP / CCM data actually shows
We tracked 1,847 patients across five years of continuous care-plan reviews. The patients who stayed in the plan beat the patients who dropped out by clinically significant margins on every measured outcome.
ReadPREDICT vs Framingham: why New Zealand's CVD risk tool catches Pacific patients Framingham misses
Aotearoa New Zealand replaced Framingham with PREDICT in 2018 — and the equity case for the swap keeps getting stronger every year of follow-up data.
ReadCare plan sync between practitioner and patient app: the technical story behind a five-year relationship
A care plan that lives only inside the EMR is a care plan that the patient cannot act on. Here's how MedMETs keeps a live, encrypted, audit-trailed sync between the practitioner web app and the patient's phone — for the entire life of the relationship.
ReadTelehealth past sunset: how dark mode and AI scribing change the after-hours clinic
Telehealth runs late. Documentation runs later. Pairing a real dark theme with ambient scribing turns the 9pm consult from a slog into a clean handover — for the clinician and for tomorrow's case.
ReadOHIP K-codes: the Ontario family-physician premiums most miss every quarter
Ontario's K-codes — preventive-care and complex-care premiums — are worth $15–60 per encounter to family physicians. The median Ontario FP claims them on under 30% of eligible visits.
ReadThe AI scribe and the care plan are not separate products — and choosing them separately is the mistake
Most practices buy an ambient scribe and a care-plan module from different vendors and wire them together with goodwill. The result is two half-products. Here's what changes when one platform does both.
ReadThe five universal documentation rules every healthcare system shares — and the one your scribe must enforce
Strip back the country-specific structures and there are five documentation principles every payer, every regulator, every audit looks for. Get these right and the rest is form-filling.
ReadHow an ambient AI clinical scribe actually works — and what the marketing leaves out
Most clinicians evaluating AI scribes have never seen what happens between the patient speaking and the note appearing. Here's what's really under the hood.
ReadAmbient AI scribes vs typing: a 12-week productivity study in primary care
Twelve weeks of side-by-side data from a 14-clinician practice — what changed when the keyboard disappeared.
ReadHeidi vs Lyrebird vs MedMETs: an honest 3-way comparison from someone who's used all three
Australia has three serious ambient AI scribe contenders. They're not equivalent. Here's where each one wins, where each one loses, and what to pick when.
ReadAUSDRISK at age 18: why the new screening threshold is going to change Monday morning
Diabetes Australia's updated AUSDRISK guidance brings the recommended starting age down to 18 for high-risk groups. The conversation in the consult room shifts with it.
ReadThe GPMP gold mine: how to claim MBS 721 without burning a Wednesday afternoon
Most Australian GPs leave $40,000+ a year on the table. The blocker isn't the patient — it's the 47 minutes of paperwork. Here's the fix.
ReadHeidi vs MedMETs: three weeks of side-by-side use, honestly
Heidi is the most popular ambient AI scribe in Australian general practice. MedMETs is the newer entrant with broader scope. Our clinical lead used both for three weeks each.
ReadThe 715 health check: the most undervalued MBS item on the Aboriginal and Torres Strait Islander roster
MBS 715 funds an annual comprehensive health assessment for ATSI patients. It pays $238, takes 25-40 minutes, and changes outcomes — and most ATSI patients have never been offered one.
ReadWhat changed in NICE NG59 — and what your scribe should be doing about it
The 2024 update to NG59 quietly shifted the imaging-first answer for non-traumatic lower back pain. Here's what every clinical AI tool should be flagging.
ReadLiving care plans vs paper care plans: what changes when the patient sees it too
A paper care plan dies in a drawer. A care plan that lives on the patient's phone gets a 73% completion rate. The difference matters more than the document.
ReadLyrebird vs MedMETs: the 47-second-per-consult difference that adds up to 9 hours a month
Lyrebird Health's voice technology is among the best in market. MedMETs's workflow integration is tighter. Per consult, the time difference is 47 seconds. Per clinic, it's a different story.
ReadCervical screening every 5 years isn't safe for everyone: the Australian exceptions you can't afford to forget
Australia moved to 5-yearly HPV-based cervical screening in 2017. Most patients are fine. The exceptions — when annual or 18-monthly screening is still indicated — get missed.
ReadFive questions every clinic should ask before signing a contract with an AI scribe vendor
The marketing pages all look the same. The contracts are where the actual product lives. Here are the five questions whose answers will save you a year of regret.
ReadItem 732 reviews: the underclaimed half of GPMP revenue every clinic forgets
MBS 721 gets the headlines. MBS 732 is where the recurring revenue actually lives. Most Australian clinics claim it for less than 30% of their active GPMPs.
ReadWhy your AI scribe will hit a ceiling — and what comes after
Most clinics see a 30-40% productivity gain from an AI scribe in months 1-3. Then it plateaus. The next gain comes from integrating the scribe with everything else.
ReadMBS 699 Heart Health Check: the 20-minute item that's already changed your patient's BP
Introduced in 2019, MBS 699 funds a 20-minute cardiovascular risk assessment every two years. Most Australian GPs still haven't claimed it.
ReadGPMP, NHS QOF, CMS Chronic Care: building one care plan that works in every country
How we mapped three radically different national billing systems onto a single patient-facing care plan model.
ReadThe Mental Health Care Plan you probably underuse, and the patients it changes
MBS 2700/2710 unlocks 10 subsidised psychology sessions for a patient. Most GPs draft fewer than three a year. The bar for who qualifies is lower than you think.
ReadCitation safety in clinical AI: what most scribes get wrong, and the test you can run on any tool in 60 seconds
An AI scribe that confidently cites a fictional guideline is worse than one that doesn't cite at all. Here's the 60-second test to run on any tool before you trust it.
ReadThe 75-and-over health assessment: the MBS item that catches what every Australian over-75 doesn't volunteer
MBS 703/705/707 funds an annual comprehensive assessment for over-75s. Pays $238 to $337 depending on time. Catches falls, cognition, depression, polypharmacy — usually before family does.
ReadCCMP: the chronic-care item Australian GPs almost never claim, and the patients who need it most
Item 230 is the Chronic Disease Management item for patients with multiple, severe, ongoing conditions. It pays more than a GPMP and goes mostly unbilled.
ReadVoice-to-note isn't AI — and why the distinction matters more than vendors want you to know
Half the tools marketed as 'AI medical scribes' are voice-to-text with formatting on top. They're not AI in any meaningful sense. The difference shows up the moment a consult gets complex.
ReadMBS 715 in practice: what the Aboriginal Health Assessment actually looks like, and why most clinics get it wrong
It's not a longer 715-coded GP consult. It's a structured, culturally appropriate annual review with specific required elements. Here's what RACGP actually expects.
ReadPre-consult triage: the 7 minutes you didn't know you were spending
What happens when patients answer the basic history questions on their phone before the visit — and why it changes the consult.
ReadThe asthma care plan most Australian GPs draft once and never review — and the spirometry numbers that should trigger it
Asthma is the most common chronic condition in Australian general practice and the least-reviewed care plan. The cost shows up in winter ED admissions.
ReadWhich AI scribe note format do you actually need: SOAP, BIRP, HPI, or something custom?
SOAP is the default. It's not always the right answer. Mental health uses BIRP. Acute presentations are cleaner in HPI. Choosing wrong adds friction every consult.
ReadThe bowel-cancer kit gathering dust on Australian kitchen counters: why uptake is 41% and how to move it
The National Bowel Cancer Screening Program mails free FOBT kits to every Australian 50-74. Uptake sits at 41%. The unscreened group is exactly where the diagnoses are.
ReadType 2 diabetes care plans in Australia: the four MBS items most GPs leave on the table
T2DM management in Australian general practice should generate ~$680 of MBS revenue per patient per year. The national average is closer to $310.
ReadAmbient AI vs dictation scribes: which one your clinic actually needs
Ambient AI listens to the consult passively. Dictation requires the clinician to speak the note. Both are 'AI scribes' in the marketing. They're not the same tool.
ReadAustralia is rolling out lung-cancer screening with LDCT in 2025. Most of your eligible patients don't know.
From mid-2025, the National Lung Cancer Screening Program will offer biennial LDCT to eligible high-risk Australians. Eligibility hinges on pack-year history. Here's how to identify your cohort now.
ReadPrivacy by design — what 'RLS-enforced' actually means for your patients
Most platforms add privacy via app code. We chose to enforce it in the database. Here's why that matters, plainly.
ReadTeam Care Arrangements (MBS 723): the second half of every GPMP nobody talks about
Item 723 unlocks five Medicare-subsidised allied health visits per patient per year. It pays $130. It takes ten minutes. Half of all Australian GPMPs skip it.
ReadBreast density is on every Australian woman's mammogram report. Almost no GP brings it up.
BreastScreen Australia reports density category on every screening mammogram. 43% of women aged 50-74 have category C or D density — meaning a standard mammogram misses cancers a supplemental ultrasound would catch.
ReadPSA screening is back in the conversation, and Australian GPs are quietly recalibrating
The 2024 RACGP guideline shifted from 'shared decision-making after age 50' to a more proactive position for men 50-69 with risk factors. The shift matters more than it sounds.
ReadRACGP / BMJ-style note generation: how we get cited references right
The prompt + retrieval design that keeps clinical citations real, current, and clickable.
ReadAustralia has the highest melanoma rate in the world. Most GPs don't have a routine skin-check workflow.
1 in 13 Australians will develop melanoma. Annual skin checks save lives. Yet most GP practices don't have a structured skin-check workflow — it gets handled ad-hoc, badly.
ReadCervical self-collection has been available in Australia since 2022. Patient awareness sits at 7%.
All Australian women aged 25-74 can now self-collect their cervical screening sample. The participation rate among under-screened women has barely moved — because nobody told them.
ReadFrom scribe to co-pilot: why evidence-backed AI matters in primary care
The shift from 'AI that types for you' to 'AI that thinks alongside you' isn't a feature — it's a philosophy.
ReadThe patient mobile app: turning the consult into a continuous conversation
Why we built the patient app and why every primary-care platform needs one.
ReadWhy we don't use the words 'streak' or 'wellness score' anywhere in our patient app
Gamification works against patients with chronic disease. We made a deliberate choice to leave it out.
ReadDesigning AI safety into clinical workflows — five rules from one year of deployment
After 12 months of clinical AI deployment, here are the rules we won't compromise on.
Read
Subscribe
One email per post. Never anything else.
Subscribe below and we'll send each new post when it ships — release notes, clinical practice, compliance.
Subscribe
One email per post. No newsletters, no marketing drip, no tracking pixels.
We'll only use this address to send new posts. Unsubscribe with one click.
Three running threads
What you'll see in your inbox
Clinical practice
Reflections on documentation, AI in the consult room, and how clinical workflows are shifting with ambient scribing — written by the clinicians on our team.
Compliance + security
How we think about HIPAA, GDPR, SOC 2, and the day-to-day work of running a healthcare platform. Plus notable industry events.
Get the newsletter in your inbox
Subscribe above and we'll send each new post when it goes live — product release notes, clinical practice, compliance perspective. No other email, no marketing nonsense.